Akèy › Metiyè › Regulatory Affairs Specialists › Marlborough, MA
Regulatory Affairs Specialists nan Marlborough, MA: Salè H-1B
23 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Marlborough, MA. Salè baz medyàn ofri $104,978; mwatye mitan $84,968–$121,393.
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo II (kalifye) | $83,308 |
| Nivo III (eksperyans) | $98,822 |
| Nivo IV (plen kompetans) | $142,677 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Boston Scientific Corporation | 11 | $142,677 |
| AngioDynamics, Inc. | 3 | $85,186 |
| Candela Corporation | 2 | $88,822 |
| Global Pharmatek LLC | 1 | $108,160 |
| Sumitomo Pharma Oncology, Inc. | 1 | $114,298 |
| GE HealthCare Inc. | 1 | $105,000 |
| CQV Associates Inc. | 1 | $75,982 |
| ModernaTX, Inc. | 1 | $91,478 |
| Unicon Pharma Inc | 1 | $81,744 |
| Kennedy International Software Inc | 1 | $75,982 |
Tit travay
- Principal Regulatory Affairs Specialist5
- Regulatory Affairs Specialist II3
- Sr. Regulatory Affairs Specialist2
- Clinical Affairs Specialist1
- Computer Systems Validation Specialist1
- Manager, Quality Management Systems1
- Quality Lead Specialist - Life Sciences Quality1
- Clinical Affairs Associate1
- Sr. Scientific Communication Specialist1
- Sr. Specialist, Regulatory Affairs1
- Senior Regulatory Affairs Specialist1
- Clinical and Regulatory Data Analyst1
- Sr. Specialist, Quality Assurance1
- Sr. Clinical Operations Regulatory Specialist1
- QMS Consultant1
Pwonse H-1B nan Marlborough, MA →
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).